Spreadsheet Data
Audit the saved peer set and the method inputs behind the blended fair value.
Review the saved peer set across price, scale, operating metrics, and raw valuation multiples.
| Peer | Price | Market Cap | Enterprise Value | Revenue | EBITDA |
|---|
| Net Income |
|---|
| P/E |
|---|
| P/S |
|---|
| EV/EBITDA |
|---|
EV EVH Evolent Health, Inc. FY ended Feb 16, 2026 | $4.60 | $520.07M | $1.60B | $1.88B | -$364.53M | -$534.51M | -0.91x | 0.28x | — |
CV CVS CVS HEALTH Corp FY ended Feb 04, 2026 | $93.06 | $119.02B | $250.00B | $402.07B | $9.41B | $1.77B | 66.95x | 0.30x | 20.16x |
DO DOCS Doximity, Inc. FY ended Mar 31, 2026 | $26.73 | $4.81B | $4.63B | $644.86M | $264.41M | $196.05M | 27.28x | 7.45x | 16.93x |
CR CRTO Criteo S.A. FY ended Feb 19, 2026 | $17.46 | $855.50M | $1.38B | $1.94B | $323.34M | $144.60M | 6.61x | 0.44x | 4.14x |
See which peer averages feed the weighted fair value and which methods are excluded.
| Method | Type | Avg. Multiple | Coverage | Implied Equity Value | Fair Value / Share | Status |
|---|---|---|---|---|---|---|
EV / EBITDA EVActive | Enterprise Multiple | 14.06x | 3/4 | $1.10B | $3.24 | Included in the active peer mix. |
Price / Sales PSActive | Equity Multiple | 2.12x | 4/4 | $1.69B | $4.96 | Included in the active peer mix. |
Price / Earnings PEActive | Equity Multiple | 24.98x | 4/4 | $760.45M | $2.24 | Included in the active peer mix. |
Open the saved peer table used to audit the fair value view.
| Peer | Price | Market Cap | Enterprise Value | Revenue | EBITDA | Net Income | P/E | P/S | EV/EBITDA |
|---|---|---|---|---|---|---|---|---|---|
EV EVH Evolent Health, Inc. FY ended Feb 16, 2026 | $4.60 | $520.07M | $1.60B | $1.88B | -$364.53M | -$534.51M | -0.91x | 0.28x | — |
CV CVS CVS HEALTH Corp FY ended Feb 04, 2026 | $93.06 | $119.02B | $250.00B | $402.07B | $9.41B | $1.77B | 66.95x | 0.30x | 20.16x |
DO DOCS Doximity, Inc. FY ended Mar 31, 2026 | $26.73 | $4.81B | $4.63B | $644.86M | $264.41M | $196.05M | 27.28x | 7.45x | 16.93x |
CR CRTO Criteo S.A. FY ended Feb 19, 2026 | $17.46 | $855.50M | $1.38B | $1.94B | $323.34M | $144.60M | 6.61x | 0.44x | 4.14x |
Open the peer-average inputs behind the weighted result.
| Method | Type | Avg. Multiple | Coverage | Implied Equity Value | Fair Value / Share | Status |
|---|---|---|---|---|---|---|
EV / EBITDA EVActive | Enterprise Multiple | 14.06x | 3/4 | $1.10B | $3.24 | Included in the active peer mix. |
Price / Sales PSActive | Equity Multiple | 2.12x | 4/4 | $1.69B | $4.96 | Included in the active peer mix. |
Price / Earnings PEActive | Equity Multiple | 24.98x | 4/4 | $760.45M | $2.24 | Included in the active peer mix. |